{"id":31,"date":"2012-03-08T20:30:51","date_gmt":"2012-03-08T11:30:51","guid":{"rendered":"http:\/\/urology.dept.med.gunma-u.ac.jp\/?p=31"},"modified":"2012-03-23T17:29:24","modified_gmt":"2012-03-23T08:29:24","slug":"2009announcement","status":"publish","type":"post","link":"https:\/\/urology.dept.med.gunma-u.ac.jp\/?p=31","title":{"rendered":"2009\u5e74\u3000\u5b66\u4f1a\u767a\u8868"},"content":{"rendered":"
    \n
  1. Ito K, Miyamoto S, Yamamoto T, Suzuki K and Yamanaka H\uff1aImpact of pretreatment factors, biopsy Gleason grade volume index and post treatment nadir PSA on cause-specific and overall survival in patients with stage IV prostate cancer. 2nd World Congress on Controversies in Urology (CURy), Feb. 6, 2009, Lisbon, Portugal.<\/li>\n
  2. Arai S, Shibata Y, Miyashiro Y, Kashiwagi B, Tomaru Y, Kobayashi M, Honma S and Suzuki K\uff1aEffect of castration monotherapy on the levels of adrenal androgens in cancerous prostatic tissues. 24th Annual European Association of Urology Congress, Mar. 20, 2009, Stockholm, Sweden.<\/li>\n
  3. Ito K\uff1aJapanese Prospective Cohort Study of Screening for Prostate Cancer (JPSPC): The Study Concept and the First Analyses on Compliance and Contamination for the PSA test. 24th Annual European Association of Urology Congress JUA-EUA joint session, Mar. 17, 2009, Stockholm, Sweden.<\/li>\n
  4. Koike H, Sekine Y, Morikawa Y, Arai S, Huruya Y, Matsui H, Shibata Y and Suzuki K\uff1aSurvivin is associated with cell proliferation and plays a role in 1a,25-dihydroxyvitamin D3 induced cell growth inhibition in prostate cancer. 24th Annual European Association of Urology Congress, Mar. 20, 2009, Stockholm, Sweden.<\/li>\n
  5. Koike H, Sekine Y, Morikawa Y, Huruya Y, Matsui H and Suzuki K\uff1aFarnesyl-diphosphate farnesyltransferase 1 is associated with the growth of renal cancer: Association with anticancer effect of statin. 24th Annual European Association of Urology Congress, Mar. 20, 2009, Stockholm, Sweden.<\/li>\n
  6. Shibata Y, Arai S, Koike H, Ito K and Suzuki K\uff1aUsefulness of real-time transrectal ultrasound navigation during holmium laser enucleation of the prostate. 24th Annual European Association of Urology Congress, Mar. 18, 2009, Stockholm, Sweden.<\/li>\n
  7. Shibata Y, Arai S, Kashiwagi B, Miyoshi Y, Honma S, Okuyama M, Kubota Y and Suzuki K\uff1aEvaluation of androgen concentrations in cancerous and non-cancerous region in surgically excised human prostate speimen. 24th Annual European Association of Urology Congress, Mar. 19, 2009, Stockholm, Sweden.<\/li>\n
  8. Arai S, Shibata Y, Miyashiro Y, Kashiwagi B, Tomaru Y, Kobayashi M, Honma S and Suzuki K\uff1aAge-related changes of adrenal androgen and estrogen levels in the prostatic tissue with benign prostatic hyperplasia. 104th Annual Meeting of American Urological Association, Apr. 28, 2009, Chicago, USA.<\/li>\n
  9. Ito K, Yamamoto T, Miyakubo M, Takechi H, Ohi M, Shibata Y and Suzuki K\uff1aImpact of body mass index on serum PSA levels and PSA velocities in Japanese males. 104th Annual Meeting of American Urological Association, Apr. 26, 2009, Chicago, USA.<\/li>\n
  10. Ito K, Yamamoto T, Miyakubo M, Takechi H, Ohi M and Suzuki K\uff1aImpact of insulin-like growth factor (IGF) kinetics on the development of prostate cancer: age-adjusted and baseline PSA-adjusted case control study. 104th Annual Meeting of American Urological Association, Apr. 29, 2009, Chicago, USA.<\/li>\n
  11. Ito K, Yamamoto T, Suzuki K, Kobayashi M, Takezawa Y, Takechi H and Tomaru Y\uff1aJapanese Prospective Cohort Study of Screening for Prostate Cancer (JPSPC): analyses on compliance, contamination and mortality until 2007 (Gunma section). 104th Annual Meeting of American Urological Association, Apr. 29, 2009, Chicago, USA.<\/li>\n
  12. Ito K, Miyakubo M, Yamamoto T, Takechi H, Ohi M and Suzuki K\uff1aLong-term risk of developing clinically manifested prostate cancer in men with negative biopsy results at the initial multiple-core prostate biopsy. 104th Annual Meeting of American Urological Association, Apr. 29, 2009, Chicago, USA.<\/li>\n
  13. Ito K, Yamamoto T, Miyakubo M, Takechi H, Ohi M and Suzuki K\uff1aImpact of exposure rate of prostate specific antigen (PSA) screening on incidence of metastatic prostate cancer in Japan. 104th Annual Meeting of American Urological Association, Apr. 29, 2009, Chicago, USA.<\/li>\n
  14. Ito K, Miyakubo M, Yamamoto T, Ohi M, Takechi H and Suzuki K\uff1aImpact of low dose finasteride for the treatment of androgenic alopecia on serum prostate specific antigen (PSA) levels in men participated in population-based screening for prostate cancer. 104th Annual Meeting of American Urological Association, Apr. 26, 2009, Chicago, USA.<\/li>\n
  15. Koike H, Sekine Y, Morikawa Y, Arai S, Huruya Y, Matsui H, Shibata Y and Suzuki K\uff1aSurvivin is associated with cell proliferation and plays a role in 1a,25-dihydroxyvitamin D3 induced cell growth inhibition in prostate cancer. 104th Annual Meeting of American Urological Association, Apr. 26, 2009, Chicago, USA.<\/li>\n
  16. Koike H, Sekine Y, Morikawa Y, Furuya Y, Matsui H and Suzuki K\uff1aFarnesyl-diphosphate farnesyltransferase 1 is associated with the growth of renal cancer: Association with anticancer effect of statin. 104th Annual Meeting of American Urological Association, Apr. 26, 2009, Chicago, USA.<\/li>\n
  17. Shibata Y, Arai S, Koike H, Hatori M, Ito K and Suzuki K\uff1aUsefulness of real-time transrectal ultrasound navigation during holmium laser enucleation of the prostate. 104th Annual Meeting of American Urological Association, Apr. 29, 2009, Chicago, USA.<\/li>\n
  18. \u4f0a\u85e4\u4e00\u4eba\uff1a\u524d\u7acb\u817a\u764c\u691c\u8a3a\uff1a\u8a55\u4fa1\u3092\u3081\u3050\u308b\u81e8\u5e8a\u533b\u3068\u75ab\u5b66\u8005\u306e\u5bfe\u7acb\u3068\u771f\u5b9f. \u7b2c21\u56de\u79cb\u7530\u770c\u524d\u7acb\u817a\u764c\u7814\u7a76\u4f1a \u7279\u5225\u8b1b\u6f14, 2009\u5e7411\u670819\u65e5, \u79cb\u7530.<\/li>\n
  19. \u4f0a\u85e4\u4e00\u4eba\uff1aPSA\u691c\u8a3a\uff5e\u63fa\u308b\u304e\u306a\u3044\u4e8b\u5b9f\u3068\u63fa\u308c\u308b\u975e\u5c02\u9580\u5bb6\u306e\u30b3\u30e1\u30f3\u30c8\u30fb\u30de\u30b9\u30b3\u30df\u5831\u9053\uff5e. \u5927\u962a\u6ccc\u5c3f\u5668\u79d1\u81e8\u5e8a\u533b\u4f1a\u7b2c55\u56de\u5b66\u8853\u96c6\u4f1a \u7279\u5225\u8b1b\u6f14, 2009\u5e745\u67089\u65e5, \u5927\u962a.<\/li>\n
  20. \u91ce\u6751\u660c\u53f2\u3001\u5927\u6728\u3000\u4eae\u3001\u65b0\u4e95\u8aa0\u4e8c\u3001\u53e4\u8c37\u6d0b\u4ecb\u3001\u65b0\u7530\u8cb4\u58eb\u3001\u68ee\u5ddd\u6cf0\u5982\u3001\u897f\u4e95\u660c\u5f18\u3001\u5c0f\u6c60\u79c0\u548c\u3001\u66f2\u3000\u53cb\u5f18\u3001\u677e\u4e95\u3000\u535a\u3001\u5c71\u672c\u3000\u5de7\u3001\u67f4\u7530\u5eb7\u535a\u3001\u7fbd\u9ce5\u57fa\u660e\u3001\u9234\u6728\u548c\u6d69\u3001\u5c0f\u6797\u5e79\u7537\uff1a\u6ccc\u5c3f\u5668\u79d1\u306b\u304a\u3051\u308b\u5185\u8996\u93e1\u4e0b\u624b\u8853\u306e\u30c8\u30ec\u30fc\u30cb\u30f3\u30b0\u3068\u8a8d\u5b9a\u5236\u5ea6. \u7b2c13\u56de\u7fa4\u99ac\u770c\u5185\u8996\u93e1\u5916\u79d1\u7814\u7a76\u4f1a, 2009\u5e742\u670810\u65e5, \u524d\u6a4b.<\/li>\n
  21. \u53e4\u8c37\u6d0b\u4ecb\u3001\u65b0\u4e95\u8aa0\u4e8c\u3001\u65b0\u7530\u8cb4\u58eb\u3001\u68ee\u5ddd\u6cf0\u5982\u3001\u95a2\u6839\u82b3\u5cb3\u3001\u91ce\u6751\u660c\u53f2\u3001\u897f\u4e95\u660c\u5f18\u3001\u5c0f\u6c60\u79c0\u548c\u3001\u66f2\u3000\u53cb\u5f18\u3001\u677e\u4e95\u3000\u535a\u3001\u5c71\u672c\u3000\u5de7\u3001\u67f4\u7530\u5eb7\u535a\u3001\u7fbd\u9ce5\u57fa\u660e\u3001\u4f0a\u85e4\u4e00\u4eba\u3001\u9234\u6728\u548c\u6d69\uff1a\u7fa4\u99ac\u5927\u5b66\u306b\u304a\u3051\u308b\uff2e\uff33\uff34\u306e\u53d6\u308a\u7d44\u307f. \u7fa4\u99acurological meeting, 2009\u5e742\u6708, \u524d\u6a4b.<\/li>\n
  22. \u4f0a\u85e4\u4e00\u4eba\uff1aPSA\u691c\u8a3a\u306e\u5229\u76ca\u3068\u4e0d\u5229\u76ca\uff1a\u81e8\u5e8a\u533b\u306e\u8996\u70b9\u304b\u3089. \u5317\u4e5d\u5dde\u6ccc\u5c3f\u5668\u7814\u7a76\u4f1a \u7279\u5225\u8b1b\u6f14, 2009\u5e7410\u670810\u65e5, \u5c0f\u5009.<\/li>\n
  23. \u4f0a\u85e4\u4e00\u4eba\uff1a\u4e16\u754c\u306e\u524d\u7acb\u817a\u304c\u3093\u691c\u8a3a\u7814\u7a76\u30ec\u30d3\u30e5\u30fc\u3068\u65e5\u672c\u3067\u9032\u884c\u4e2d\u306e\u30af\u30e9\u30b9\u30bf\u30fb\u30b3\u30db\u30fc\u30c8\u7814\u7a76\u306e\u91cd\u8981\u6027. \u4f50\u4e16\u4fdd\u5e02\u524d\u7acb\u817a\u304c\u3093\u691c\u8a3a\u5b66\u8853\u8b1b\u6f14\u4f1a, 2009\u5e743\u67086\u65e5, \u4f50\u4e16\u4fdd.<\/li>\n
  24. \u5742\u672c\u4eae\u4e00\u90ce\u3001\u5927\u8c37\u548c\u6b4c\u3001\u67cf\u6728\u6587\u8535\u3001\u658e\u85e4\u4f73\u9686\u3001\u5185\u7530\u9054\u4e5f\u3001\u7af9\u6fa4\u3000\u8c4a\u3001\u5c0f\u6797\u5e79\u7537\u3001\u539f\u7530\u8015\u4f5c\u3001\u6cb3\u6751\u82f1\u5c06\u3001\u4ef2\u672c\u5b97\u5065\uff1a\u5c0f\u7dda\u6e90\u7642\u6cd5\u5f8c\u306bTUR-P\u3092\u65bd\u884c\u3057\u305f\uff11\u4f8b. \u7b2c\uff16\u56de\u524d\u7acb\u817a\u764c\u5bc6\u5c01\u5c0f\u7dda\u6e90\u6c38\u4e45\u633f\u5165\u6cbb\u7642\u7814\u7a76\u4f1a, 2009\u5e747\u670819\u65e5, \u6771\u4eac.<\/li>\n
  25. \u4f0a\u85e4\u4e00\u4eba\uff1aStage\uff23\u524d\u7acb\u817a\u304c\u3093\u306e\u6cbb\u7642\u6226\u7565\uff1a\u5c40\u6240\u9032\u884c\u524d\u7acb\u817a\u764c\u306b\u5bfe\u3059\u308b\u5185\u5206\u6ccc\u7642\u6cd5\u306e\u81f3\u9069\u4f75\u7528\u65b9\u6cd5. \u7b2c25\u56de\u524d\u7acb\u817a\u30b7\u30f3\u30dd\u30b8\u30a6\u30e0 \u30d1\u30cd\u30eb\u30c7\u30a3\u30b9\u30ab\u30c3\u30b7\u30e7\u30f3, 2009\u5e7412\u670813\u65e5, \u6771\u4eac.<\/li>\n
  26. \u4f0a\u85e4\u4e00\u4eba\uff1a\u524d\u7acb\u817a\u304c\u3093\u3067\u6b7b\u306a\u306a\u3044\u305f\u3081\u306b\uff1a\u4e16\u754c\u6a19\u6e96\u306e\u524d\u7acb\u817a\u304c\u3093\u691c\u8a3a\u30cd\u30c3\u30c8\u30ef\u30fc\u30af\u69cb\u7bc9\u306e\u91cd\u8981\u6027. \u6803\u6728\u770c\u7acb\u304c\u3093\u30bb\u30f3\u30bf\u30fc\u30fb\u30b0\u30e9\u30f3\u30c9\u30ab\u30f3\u30d5\u30a1\u30ec\u30f3\u30b9, 2009\u5e742\u670819\u65e5, \u5b87\u90fd\u5bae.<\/li>\n
  27. \u65b0\u4e95\u8aa0\u4e8c\u3001\u67f4\u7530\u5eb7\u535a\u3001\u5c0f\u6c60\u79c0\u548c\u3001\u5bae\u4e45\u4fdd\u771f\u610f\u3001\u68ee\u5ddd\u6cf0\u5982\u3001\u5ca1\u672c\u4e98\u5e73\u3001\u91ce\u6751\u660c\u53f2\u3001\u677e\u4e95\u3000\u535a\u3001\u7fbd\u9ce5\u57fa\u660e\u3001\u4f0a\u85e4\u4e00\u4eba\u3001\u9234\u6728\u548c\u6d69\uff1a\u30db\u30eb\u30df\u30a6\u30e0\u30ec\u30fc\u30b6\u30fc\u524d\u7acb\u817a\u6838\u51fa\u8853(HoLEP)100\u4f8b\u306e\u691c\u8a0e. \u7b2c23\u56de\u65e5\u672cEndourology\u30fbESWL\u5b66\u4f1a\u7dcf\u4f1a, 2009\u5e7411\u670812\u65e5, \u6771\u4eac.<\/li>\n
  28. \u91ce\u6751\u660c\u53f2\u3001\u5c0f\u6c60\u79c0\u548c\u3001\u677e\u4e95\u3000\u535a\u3001\u67f4\u7530\u5eb7\u535a\u3001\u7fbd\u9ce5\u57fa\u660e\u3001\u4f0a\u85e4\u4e00\u4eba\u3001\u9234\u6728\u548c\u6d69\u3001\u5c0f\u6797\u5e79\u7537\uff1a\u7d50\u6838\u814e\u3068\u540c\u5074\u306e\u526f\u814e\u816b\u760d\u306b\u5bfe\u3057\u3066\u5f8c\u8179\u8154\u93e1\u4e0b\u306b\u814e\u526f\u814e\u6458\u9664\u8853\u3092\u65bd\u884c\u3057\u305f\u4e00\u4f8b. \u7b2c23\u56de\u65e5\u672cEndourology\u30fbESWL\u5b66\u4f1a\u7dcf\u4f1a, 2009\u5e7411\u670812\u65e5, \u6771\u4eac.<\/li>\n
  29. \u4f0a\u85e4\u4e00\u4eba\uff1a\u65b0\u305f\u306a\u304c\u3093\u691c\u8a3a\u691c\u67fb\u65b9\u6cd5\u306e\u6709\u52b9\u6027\uff1aPSA\u691c\u67fb. \u7b2c17\u56de\u65e5\u672c\u304c\u3093\u691c\u8a3a\u30fb\u8a3a\u65ad\u5b66\u4f1a\u7dcf\u4f1a \u30b7\u30f3\u30dd\u30b8\u30a6\u30e0\uff13, 2009\u5e749\u67085\u65e5, \u540d\u53e4\u5c4b.<\/li>\n
  30. \u4f0a\u85e4\u4e00\u4eba\u3001\u8d64\u5009\u529f\u4e00\u90ce\u3001\u5c71\u672c\u3000\u5de7\u3001\u5bae\u4e45\u4fdd\u771f\u610f\u3001\u7530\u4e2d\u5553\u5e79\u3001\u5cf6\u5d0e\u3000\u6df3\u3001\u5c71\u4e2d\u82f1\u58fd\u3001\u524d\u7acb\u817a\u304c\u3093\u64b2\u6ec5\u63a8\u9032\u59d4\u54e1\u4f1a\u30e1\u30f3\u30d0\u30fc\uff1a2007\u5e74\u5ea6\u306e\u524d\u7acb\u817a\u304c\u3093\u691c\u8a3a\uff1a\u75be\u60a3\u7d99\u7d9a\u7814\u7a76\u30fb\u5bfe\u7167\u7814\u7a76\u306e\u691c\u8a3a\u7d50\u679c. \u7b2c47\u56de\u65e5\u672c\u764c\u6cbb\u7642\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a, 2009\u5e7410\u670823\u65e5, \u6a2a\u6d5c.<\/li>\n
  31. \u4f0a\u85e4\u4e00\u4eba\uff1a\u524d\u7acb\u817a\u304c\u3093\uff0d\u691c\u8a3a\u306e\u610f\u7fa9\uff1a\u6b27\u5dde\u3068\u7c73\u56fd\u306e\u7121\u4f5c\u70ba\u5316\u6bd4\u8f03\u5bfe\u7167\u8a66\u9a13(RCT)\u7d50\u679c\u306e\u691c\u8a3c\uff1a\u6ccc\u5c3f\u5668\u79d1\u81e8\u5e8a\u533b\u306e\u8996\u70b9\u304b\u3089. \u7b2c47\u56de\u65e5\u672c\u764c\u6cbb\u7642\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a \u30b7\u30f3\u30dd\u30b8\u30a6\u30e0\uff16, 2009\u5e7410\u670822\u65e5, \u6a2a\u6d5c.<\/li>\n
  32. \u65b0\u4e95\u8aa0\u4e8c\u3001\u5bae\u4ee3\u597d\u901a\u3001\u67f4\u7530\u5eb7\u535a\u3001\u672c\u9593\u8aa0\u6b21\u90ce\u3001\u9234\u6728\u548c\u6d69\uff1a\u6db2\u4f53\u30af\u30ed\u30de\u30c8\u30b0\u30e9\u30d5\u30fb\u30bf\u30f3\u30c7\u30e0\u8cea\u91cf\u5206\u6790\u8a08(LC-MS\/MS)\u306b\u3088\u308b\u524d\u7acb\u817a\u7d44\u7e54\u5185E2\u5b9a\u91cf\u6cd5. \u7b2c17\u56de\u65e5\u672c\u30b9\u30c6\u30ed\u30a4\u30c9\u30db\u30eb\u30e2\u30f3\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a, 2009\u5e7411\u670814\u65e5, \u798f\u5ca1.<\/li>\n
  33. \u67f4\u7530\u5eb7\u535a\u3001\u65b0\u4e95\u8aa0\u4e8c\u3001\u67cf\u6728\u6587\u8535\u3001\u9234\u6728\u548c\u6d69\uff1a\u30a2\u30f3\u30c9\u30ed\u30b2\u30f3\u306e\u30ce\u30f3\u30b2\u30ce\u30df\u30c3\u30af\u4f5c\u7528\u306b\u3088\u308b\u524d\u7acb\u817a\u8840\u6d41\u8abf\u7bc0. \u7b2c17\u56de\u65e5\u672c\u30b9\u30c6\u30ed\u30a4\u30c9\u30db\u30eb\u30e2\u30f3\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a, 2009\u5e7411\u670814\u65e5, \u798f\u5ca1.<\/li>\n
  34. \u67f4\u7530\u5eb7\u535a\uff1a\u7d4c\u76f4\u8178\u7684\u8d85\u97f3\u6ce2\u65ad\u5c64\u6cd5\u306e\u5c06\u6765\u3092\u8003\u3048\u308b\u2015\u8a3a\u65ad\u304b\u3089\u30a4\u30f3\u30bf\u30fc\u30d9\u30f3\u30b7\u30e7\u30f3\uff65\u6cbb\u7642\u3078\u306e\u5fdc\u7528\u2015 \u30db\u30eb\u30df\u30a6\u30e0\u30ec\u30fc\u30b6\u30fc\u524d\u7acb\u817a\u6838\u51fa\u8853\u6642\u306e\u30ea\u30a2\u30eb\u30bf\u30a4\u30e0TRUS\u306e\u6709\u7528\u6027. \u65e5\u672c\u8d85\u97f3\u6ce2\u533b\u5b66\u4f1a\u7b2c82\u56de\u5b66\u8853\u96c6\u4f1a\u3000\u30b7\u30f3\u30dd\u30b8\u30a6\u30e0, 2009\u5e745\u670822\u65e5, \u6771\u4eac.<\/li>\n
  35. \u65b0\u4e95\u8aa0\u4e8c\u3001\u5bae\u4ee3\u597d\u901a\u3001\u67f4\u7530\u5eb7\u535a\u3001\u672c\u9593\u8aa0\u6b21\u90ce\u3001\u9234\u6728\u548c\u6d69\uff1aLC-MS\/MS \u306b\u3088\u308b\u524d\u7acb\u817a\u7d44\u7e54\u5185\u30b9\u30c6\u30ed\u30a4\u30c9\u30db\u30eb\u30e2\u30f3\u5b9a\u91cf\u6cd5. \u7b2c82\u56de\u65e5\u672c\u5185\u5206\u6ccc\u5b66\u4f1a\u5b66\u8853\u7dcf\u4f1a, 2009\u5e744\u670823\u65e5, \u524d\u6a4b.<\/li>\n
  36. \u67f4\u7530\u5eb7\u535a\u3001\u67cf\u6728\u6587\u8535\u3001\u65b0\u4e95\u8aa0\u4e8c\u3001\u672c\u9593\u8aa0\u6b21\u90ce\u3001\u9234\u6728\u548c\u6d69\uff1a\u524d\u7acb\u817a\u306e\u8840\u6d41\u8abf\u7bc0\u6a5f\u69cb\u3068\u30db\u30eb\u30e2\u30f3\u2015\u7d30\u80de\u819c\u4e0d\u900f\u904e\u30a2\u30f3\u30c9\u30ed\u30b2\u30f3\u306e\u524d\u7acb\u817a\u8840\u6d41\u3078\u306e\u5f71\u97ff\u2015. \u7b2c82\u56de\u65e5\u672c\u5185\u5206\u6ccc\u5b66\u4f1a\u5b66\u8853\u7dcf\u4f1a, 2009\u5e744\u670823\u65e5, \u524d\u6a4b.<\/li>\n
  37. \u4f0a\u85e4\u4e00\u4eba\uff1a\u304c\u3093\u691c\u8a3a\u306e\u73fe\u6cc1\u3068\u5c06\u6765\uff1a\u524d\u7acb\u817a\u304c\u3093\u691c\u8a3a\u306e\u6700\u65b0\u60c5\u5831\u3068\u5c06\u6765\u5c55\u671b. \u7b2c50\u56de\u65e5\u672c\u4eba\u9593\u30c9\u30c3\u30af\u5b66\u4f1a\u5b66\u8853\u5927\u4f1a \u30b7\u30f3\u30dd\u30b8\u30a6\u30e0\uff12, 2009\u5e749\u67084\u65e5, \u6771\u4eac.<\/li>\n
  38. \u4f0a\u85e4\u4e00\u4eba\uff1aPSA\u691c\u8a3a\u306b\u3088\u308b\u6b7b\u4ea1\u7387\u4f4e\u4e0b\u52b9\u679c\u304c\u78ba\u5b9f\u306b\uff5e\u524d\u7acb\u817a\u304c\u3093\u691c\u8a3a\u30ac\u30a4\u30c9\u30e9\u30a4\u30f3(2009\u5e74\u8ffd\u88dc\u7248)\u306b\u3064\u3044\u3066\uff5e. \u7b2c\uff17\u56de\u65e5\u672c\u6ccc\u5c3f\u5668\u79d1\u5b66\u4f1a\u30d7\u30ec\u30b9\u30bb\u30df\u30ca\u30fc, 2009\u5e7410\u670820\u65e5, \u6771\u4eac.<\/li>\n
  39. \u65b0\u4e95\u8aa0\u4e8c\u3001\u5bae\u4ee3\u597d\u901a\u3001\u67f4\u7530\u5eb7\u535a\u3001\u767b\u4e38\u884c\u96c4\u3001\u5c0f\u6797\u5e79\u7537\u3001\u672c\u9593\u8aa0\u6b21\u90ce\u3001\u9234\u6728\u548c\u6d69\uff1a\u6db2\u4f53\u30af\u30ed\u30de\u30c8\u30b0\u30e9\u30d5\u30fb\u30bf\u30f3\u30c7\u30e0\u8cea\u91cf\u5206\u6790\u8a08(LC-MS\/MS)\u306b\u3088\u308b\u524d\u7acb\u817a\u764c\u7d44\u7e54\u4e2d\u526f\u814e\u6027\u30a2\u30f3\u30c9\u30ed\u30b2\u30f3\u306e\u5b9a\u91cf. \u7b2c97\u56de\u65e5\u672c\u6ccc\u5c3f\u5668\u79d1\u5b66\u4f1a\u7dcf\u4f1a, 2009\u5e744\u670816\u65e5, \u5ca1\u5c71.<\/li>\n
  40. \u4f0a\u85e4\u4e00\u4eba\uff1a\u524d\u7acb\u817a\u304c\u3093\u691c\u8a3a\uff1a\u30ac\u30a4\u30c9\u30e9\u30a4\u30f3\u306e\u691c\u8a3c\u3068\u5c06\u6765\u5c55\u671b. \u7b2c97\u56de\u65e5\u672c\u6ccc\u5c3f\u5668\u79d1\u5b66\u4f1a\u7dcf\u4f1a\u3000\u7279\u5225\u8b1b\u6f14\uff11, 2009\u5e744\u670816\u65e5, \u5ca1\u5c71.<\/li>\n
  41. \u67f4\u7530\u5eb7\u535a\u3001\u65b0\u4e95\u8aa0\u4e8c\u3001\u5c0f\u6c60\u79c0\u548c\u3001\u91ce\u6751\u660c\u53f2\u3001\u897f\u4e95\u660c\u5f18\u3001\u677e\u4e95\u3000\u535a\u3001\u7fbd\u9ce5\u57fa\u660e\u3001\u4f0a\u85e4\u4e00\u4eba\u3001\u9234\u6728\u548c\u6d69\uff1a\u7d4c\u5c3f\u9053\u7684\u30db\u30eb\u30df\u30a6\u30e0\u30ec\u30fc\u30b6\u30fc\u524d\u7acb\u817a\u6838\u51fa\u8853(HoLEP)\u65bd\u884c\u6642\u306e\u5265\u96e2\u6cd5\u306e\u691c\u8a0e\u2015\u3088\u308a\u8fc5\u901f\u30fb\u5b89\u5168\u306a\u624b\u8853\u3092\u3081\u3056\u3057\u3066\u2015. \u7b2c97\u56de\u65e5\u672c\u6ccc\u5c3f\u5668\u79d1\u5b66\u4f1a\u7dcf\u4f1a, 2009\u5e744\u670817\u65e5, \u5ca1\u5c71.<\/li>\n
  42. \u65b0\u4e95\u8aa0\u4e8c\u3001\u5bae\u4ee3\u597d\u901a\u3001\u67f4\u7530\u5eb7\u535a\u3001\u67cf\u6728\u6587\u8535\u3001\u767b\u4e38\u884c\u96c4 \u3001\u5c0f\u6797\u5e79\u7537\u3001\u9234\u6728\u548c\u6d69\uff1a\u6db2\u4f53\u30af\u30ed\u30de\u30c8\u30b0\u30e9\u30d5\u30fb\u30bf\u30f3\u30c7\u30e0\u8cea\u91cf\u5206\u6790\u8a08(LC-MS\/MS)\u306b\u3088\u308b\u524d\u7acb\u817a\u7d44\u7e54\u5185\u30b9\u30c6\u30ed\u30a4\u30c9\u30db\u30eb\u30e2\u30f3\u5b9a\u91cf\u6cd5. \u7b2c74\u56de\u65e5\u672c\u6ccc\u5c3f\u5668\u79d1\u5b66\u4f1a\u6771\u90e8\u7dcf\u4f1a, 2009\u5e7411\u670830\u65e5, \u677e\u672c.<\/li>\n
  43. \u4f0a\u85e4\u4e00\u4eba\uff1a\u9650\u5c40\u6027\u524d\u7acb\u817a\u304c\u3093\u306e\u30ea\u30b9\u30af\u7fa4\u5225\u6cbb\u7642\u30a2\u30c3\u30d7\u30c7\u30fc\u30c8\uff0d\u624b\u8853vs \u653e\u5c04\u7dda\u6cbb\u7642\uff0d\uff1a\u9ad8\u30ea\u30b9\u30af\u7fa4\u306b\u5bfe\u3059\u308b\u5916\u7167\u5c04+\u9ad8\u7dda\u91cf\u7387\u7d44\u7e54\u5185\u7167\u5c04\u7642\u6cd5\u306e\u6cbb\u7642\u6210\u7e3e. \u7b2c74\u56de\u65e5\u672c\u6ccc\u5c3f\u5668\u79d1\u5b66\u4f1a\u6771\u90e8\u7dcf\u4f1a\u3000\u30b7\u30f3\u30dd\u30b8\u30a6\u30e0\uff14, 2009\u5e7410\u670830\u65e5, \u677e\u672c.<\/li>\n
  44. \u67f4\u7530\u5eb7\u535a\u3001\u65b0\u4e95\u8aa0\u4e8c\u3001\u67cf\u6728\u6587\u8535\u3001\u672c\u9593\u8aa0\u6b21\u90ce\u3001\u9234\u6728\u548c\u6d69\uff1a\u7d30\u80de\u819c\u4e0d\u900f\u904e\u30a2\u30f3\u30c9\u30ed\u30b2\u30f3\u306b\u3088\u308b\u524d\u7acb\u817a\u8840\u6d41\u5236\u5fa1\u2015\u7b2c\uff12\u5831\u2015. \u7b2c74\u56de\u65e5\u672c\u6ccc\u5c3f\u5668\u79d1\u5b66\u4f1a\u6771\u90e8\u7dcf\u4f1a, 2009\u5e7410\u670829\u65e5, \u677e\u672c.<\/li>\n
  45. \u53e4\u8c37\u6d0b\u4ecb\u3001\u9ed2\u5ddd\u516c\u5e73\u3001\u7267\u91ce\u6b66\u6717\u3001\u68ee\u5ddd\u6cf0\u5982\uff1a\u5c3f\u7ba1\u4e0b\u90e8\u75c5\u5909\u3092\u6709\u3059\u308b\u5c3f\u8def\u816b\u760d\u306e\u6cbb\u7642. \u7b2c74\u56de\u65e5\u672c\u6ccc\u5c3f\u5668\u79d1\u5b66\u4f1a\u6771\u90e8\u7dcf\u4f1a, 2009\u5e7410\u670829\u65e5, \u677e\u672c.<\/li>\n
  46. \u5927\u6728\u3000\u4eae\u3001\u65b0\u7530\u8cb4\u58eb\u3001\u897f\u4e95\u660c\u5f18\u3001\u65b0\u4e95\u8aa0\u4e8c\u3001\u53e4\u8c37\u6d0b\u4ecb\u3001\u68ee\u5ddd\u6cf0\u5982\u3001\u91ce\u6751\u660c\u53f2\u3001\u5c0f\u6c60\u79c0\u548c\u3001\u66f2\u3000\u53cb\u5f18\u3001\u677e\u4e95\u3000\u535a\u3001\u5c71\u672c\u3000\u5de7\u3001\u67f4\u7530\u5eb7\u535a\u3001\u7fbd\u9ce5\u57fa\u660e\u3001\u4f0a\u85e4\u4e00\u4eba\u3001\u9234\u6728\u548c\u6d69\uff1a\u814e\u79fb\u690d\u5f8c\u306e\u56de\u8178\u60aa\u6027\u30ea\u30f3\u30d1\u816b\u306b\u3088\u308b\u8178\u91cd\u7a4d\u75c7\u306e\u4e00\u4f8b. \u7b2c51\u56de\u65e5\u672c\u6ccc\u5c3f\u5668\u79d1\u5b66\u4f1a\u7fa4\u99ac\u5730\u65b9\u4f1a, 2009\u5e742\u670821\u65e5, \u524d\u6a4b.<\/li>\n
  47. \u52a0\u85e4\u6625\u96c4\u3001\u5965\u6728\u5b8f\u5ef6\u3001\u5ca1\u5d0e\u3000\u6d69\u3001\u4e2d\u6751\u654f\u4e4b\uff1aHo:YAG\u30ec\u30fc\u30b6\u30fc\u3092\u7528\u3044\u305fTUL\u306e\u7d4c\u9a13. \u7b2c51\u56de\u65e5\u672c\u6ccc\u5c3f\u5668\u79d1\u5b66\u4f1a\u7fa4\u99ac\u5730\u65b9\u4f1a, 2009\u5e742\u670821\u65e5, \u524d\u6a4b.<\/li>\n
  48. \u5742\u672c\u4eae\u4e00\u90ce\u3001\u68ee\u5ddd\u6cf0\u5982\u3001\u65b0\u4e95\u8aa0\u4e8c\u3001\u53e4\u8c37\u6d0b\u4ecb\u3001\u65b0\u7530\u8cb4\u58eb\u3001\u91ce\u6751\u660c\u53f2\u3001\u897f\u4e95\u660c\u5f18\u3001\u5c0f\u6c60\u79c0\u548c\u3001\u66f2\u3000\u53cb\u5f18\u3001\u677e\u4e95\u3000\u535a\u3001\u5c71\u672c\u3000\u5de7\u3001\u67f4\u7530\u5eb7\u535a\u3001\u7fbd\u9ce5\u57fa\u660e\u3001\u4f0a\u85e4\u4e00\u4eba\u3001\u9234\u6728\u548c\u6d69\uff1a\u7279\u767a\u6027\u526f\u814e\u51fa\u8840\u306e\uff11\u4f8b. \u7b2c51\u56de\u65e5\u672c\u6ccc\u5c3f\u5668\u79d1\u5b66\u4f1a\u7fa4\u99ac\u5730\u65b9\u4f1a, 2009\u5e742\u670821\u65e5, \u524d\u6a4b.<\/li>\n
  49. \u5bae\u6fa4\u6176\u884c\u3001\u6a2a\u5c71\u7531\u5c31\u3001\u5927\u8c37\u548c\u6b4c\u3001\u5bae\u4e45\u4fdd\u771f\u610f\u3001\u658e\u85e4\u4f73\u9686\u3001\u5185\u7530\u9054\u4e5f\u3001\u7af9\u6fa4\u3000\u8c4a\u3001\u5c0f\u6797\u5e79\u7537\uff1aHIFU\u7642\u6cd5\u5f8c\u306e\u524d\u7acb\u817a\u764c\u306b\u5bfe\u3057\u6839\u6cbb\u7684\u524d\u7acb\u817a\u5168\u6458\u8853\u3092\u65bd\u884c\u3057\u305f\uff11\u4f8b. \u7b2c51\u56de\u65e5\u672c\u6ccc\u5c3f\u5668\u79d1\u5b66\u4f1a\u7fa4\u99ac\u5730\u65b9\u4f1a, 2009\u5e742\u670821\u65e5, \u524d\u6a4b.<\/li>\n
  50. \u5927\u6728\u3000\u4eae\u3001\u753a\u7530\u660c\u5df3\u3001\u5c0f\u6797\u5927\u5fd7\u6717\u3001\u5869\u91ce\u662d\u5f66\u3001\u7267\u91ce\u6b66\u96c4\u3001\u67f4\u5c71\u52dd\u592a\u90ce\uff1a\u30b9\u30c6\u30ed\u30a4\u30c9\u304c\u8457\u52b9\u3057\u305fCAPD\u96e2\u8131\u5f8c\u306e\u786c\u5316\u6027\u8179\u819c\u708e\u306e\u4e00\u4f8b. \u7b2c52\u56de\u65e5\u672c\u6ccc\u5c3f\u5668\u79d1\u5b66\u4f1a\u7fa4\u99ac\u5730\u65b9\u4f1a, 2009\u5e746\u670813\u65e5, \u524d\u6a4b.<\/li>\n
  51. \u52a0\u85e4\u6625\u96c4\u3001\u5927\u585a\u4fdd\u5b8f\u3001\u66f2\u3000\u53cb\u5f18\u3001\u5c0f\u5009\u6cbb\u4e4b\u3001\u9ed2\u6fa4\u3000\u529f\uff1a\u51e6\u5973\u819c\u9589\u9396\u75c7\u306b\u4f34\u3046\u5b50\u5bae\u81a3\u7559\u8840\u816b\u304c\u539f\u56e0\u3068\u8003\u3048\u3089\u308c\u305f\u5c3f\u9589\u306e\uff11\u4f8b. \u7b2c52\u56de\u65e5\u672c\u6ccc\u5c3f\u5668\u79d1\u5b66\u4f1a\u7fa4\u99ac\u5730\u65b9\u4f1a, 2009\u5e746\u670813\u65e5, \u524d\u6a4b.<\/li>\n
  52. \u5742\u672c\u4eae\u4e00\u90ce\u3001\u5927\u8c37\u548c\u6b4c\u3001\u67cf\u6728\u6587\u8535\u3001\u658e\u85e4\u4f73\u9686\u3001\u5185\u7530\u9054\u4e5f\u3001\u7af9\u6fa4\u3000\u8c4a\u3001\u5c0f\u6797\u5e79\u7537\u3001\u539f\u7530\u8015\u4f5c\u3001\u5ddd\u6751\u82f1\u5c06\u3001\u4ef2\u672c\u5b97\u5065\uff1a\u524d\u7acb\u817a\u764c\u691c\u8a3a\uff1a\u5c0f\u7dda\u6e90\u7642\u6cd5\u5f8c\u306b\u5c3f\u9589\u3068\u306a\u308a\u3001TUR-P\u3092\u65bd\u884c\u3057\u305f\uff11\u4f8b. \u7b2c52\u56de\u65e5\u672c\u6ccc\u5c3f\u5668\u79d1\u5b66\u4f1a\u7fa4\u99ac\u5730\u65b9\u4f1a, 2009\u5e746\u670813\u65e5, \u524d\u6a4b.<\/li>\n
  53. \u5bcc\u7530\u5065\u4ecb\u3001\u7267\u91ce\u6b66\u6717\u3001\u91ce\u6751\u660c\u53f2\u3001\u6a2a\u5c71\u7531\u5c31\u3001\u65b0\u4e95\u8aa0\u4e8c\u3001\u6751\u677e\u548c\u9053\u3001\u5ee3\u91ce\u6b63\u6cd5\u3001\u5bae\u4e45\u4fdd\u771f\u610f\u3001\u68ee\u5ddd\u6cf0\u5982\u3001\u5ca1\u672c\u4e98\u5e73\u3001\u5c0f\u6c60\u79c0\u548c\u3001\u677e\u4e95\u3000\u535a\u3001\u67f4\u7530\u5eb7\u535a\u3001\u7fbd\u9ce5\u57fa\u660e\u3001\u4f0a\u85e4\u4e00\u4eba\u3001\u9234\u6728\u548c\u6d69\uff1a\u30b2\u30e0\u30bf\u30b7\u30d3\u30f3\u3092\u7528\u3044\u305f\u8853\u524d\u5316\u5b66\u7642\u6cd5\u3092\u65bd\u884c\u3057\u3066\u75c5\u7406\u5b66\u7684CR\u3092\u5f97\u305f\u5c3f\u8def\u4e0a\u76ae\u764c\u306e\uff12\u75c7\u4f8b. \u7b2c52\u56de\u65e5\u672c\u6ccc\u5c3f\u5668\u79d1\u5b66\u4f1a\u7fa4\u99ac\u5730\u65b9\u4f1a, 2009\u5e746\u670813\u65e5, \u524d\u6a4b.<\/li>\n
  54. \u65b0\u7530\u8cb4\u58eb\u3001\u6ff1\u91ce\u9054\u4e5f\u3001\u5ddd\u53e3\u62d3\u4e5f\uff1a25\u5e74\u306e\u7d4c\u904e\u3067\u518d\u767a\u3057\u305f\u5de8\u5927\u524d\u7acb\u817a\u80a5\u5927\u75c7\u306e\uff11\u4f8b. \u7b2c52\u56de\u65e5\u672c\u6ccc\u5c3f\u5668\u79d1\u5b66\u4f1a\u7fa4\u99ac\u5730\u65b9\u4f1a, 2009\u5e746\u670813\u65e5, \u524d\u6a4b.<\/li>\n
  55. \u91ce\u6751\u660c\u53f2\u3001\u65b0\u4e95\u8aa0\u4e8c\u3001\u5c0f\u6c60\u79c0\u548c\u3001\u677e\u4e95\u3000\u535a\u3001\u67f4\u7530\u5eb7\u535a\u3001\u7fbd\u9ce5\u57fa\u660e\u3001\u4f0a\u85e4\u4e00\u4eba\u3001\u9234\u6728\u548c\u6d69\u3001\u5927\u5c71\u88d5\u4eae\u3001\u5c0f\u6797\u5e79\u7537\uff1a\u5f8c\u8179\u8154\u93e1\u4e0b\u814e\u6458\u9664\u8853\u306b\u304a\u3051\u308b\u814e\u830e\u90e8\u51e6\u7406\u306e\u5de5\u592b. \u7b2c52\u56de\u65e5\u672c\u6ccc\u5c3f\u5668\u79d1\u5b66\u4f1a\u7fa4\u99ac\u5730\u65b9\u4f1a, 2009\u5e746\u670813\u65e5, \u524d\u6a4b.<\/li>\n
  56. \u53e4\u8c37\u6d0b\u4ecb\u3001\u9ed2\u5ddd\u516c\u5e73\u3001\u5408\u7530\u3000\u53f2\u3001\u7267\u91ce\u6b66\u6717\uff1a\u591a\u5f69\u306a\u75c7\u72b6\u306b\u3066\u767a\u75c7\u3057\u305f\u30cf\u30c3\u30c1\u61a9\u5ba4\u75c7\u4f8b. \u7b2c52\u56de\u65e5\u672c\u6ccc\u5c3f\u5668\u79d1\u5b66\u4f1a\u7fa4\u99ac\u5730\u65b9\u4f1a, 2009\u5e746\u670813\u65e5, \u524d\u6a4b.<\/li>\n
  57. \u65b0\u4e95\u8aa0\u4e8c\u3001\u67f4\u7530\u5eb7\u535a\u3001\u51a8\u7530\u5065\u4ecb\u3001\u6a2a\u5c71\u7531\u5c31\u3001\u5ee3\u91ce\u6b63\u6cd5\u3001\u7267\u91ce\u6b66\u6717\u3001\u6751\u677e\u548c\u9053\u3001\u5bae\u4e45\u4fdd\u771f\u610f\u3001\u68ee\u5ddd\u6cf0\u5982\u3001\u5ca1\u672c\u4e98\u5e73\u3001\u91ce\u6751\u660c\u53f2\u3001\u5c0f\u6c60\u79c0\u548c\u3001\u677e\u4e95\u3000\u535a\u3001\u7fbd\u9ce5\u57fa\u660e\u3001\u4f0a\u85e4\u4e00\u4eba\u3001\u9234\u6728\u548c\u6d69\uff1a\u8853\u4e2d\u30ea\u30a2\u30eb\u30bf\u30a4\u30e0TRUS\u30aa\u30da\u30ec\u30fc\u30bf\u30fc\u3092\u7d4c\u9a13\u3057\u305f\u8853\u8005\u304c\u65bd\u884c\u3057\u305fHoLEP 10\u4f8b\u306e\u6cbb\u7642\u6210\u7e3e. \u7b2c53\u56de\u65e5\u672c\u6ccc\u5c3f\u5668\u79d1\u5b66\u4f1a\u7fa4\u99ac\u5730\u65b9\u4f1a, 2009\u5e7411\u67087\u65e5, \u524d\u6a4b.<\/li>\n
  58. \u5927\u6728\u3000\u4eae\u3001\u5869\u91ce\u662d\u5f66\u3001\u5c0f\u6797\u5927\u5fd7\u6717\u3001\u753a\u7530\u660c\u5df3\u3001\u7267\u91ce\u6b66\u96c4\u3001\u67f4\u5c71\u52dd\u592a\u90ce\uff1a\u7cbe\u5de3\u816b\u760d\u2015Leydig cell tumor\u306e\uff11\u4f8b. \u7b2c53\u56de\u65e5\u672c\u6ccc\u5c3f\u5668\u79d1\u5b66\u4f1a\u7fa4\u99ac\u5730\u65b9\u4f1a, 2009\u5e7411\u67087\u65e5, \u524d\u6a4b.<\/li>\n
  59. \u51a8\u7530\u5065\u4ecb\u3001\u7267\u91ce\u6b66\u6717\u3001\u91ce\u6751\u660c\u53f2\u3001\u6a2a\u5c71\u7531\u5c31\u3001\u65b0\u4e95\u8aa0\u4e8c\u3001\u6751\u677e\u548c\u9053\u3001\u5ee3\u91ce\u6b63\u6cd5\u3001\u5bae\u4e45\u4fdd\u771f\u610f\u3001\u68ee\u5ddd\u6cf0\u5982\u3001\u5ca1\u672c\u4e98\u5e73\u3001\u5c0f\u6c60\u79c0\u548c\u3001\u677e\u4e95\u3000\u535a\u3001\u67f4\u7530\u5eb7\u535a\u3001\u7fbd\u9ce5\u57fa\u660e\u3001\u4f0a\u85e4\u4e00\u4eba\u3001\u9234\u6728\u548c\u6d69\u3001\u733f\u6728\u548c\u4e45\uff1a\u5c0f\u5150\u306b\u767a\u75c7\u3057\u305f\u5c3f\u8def\u4e0a\u76ae\u764c\u306e\u4e00\u4f8b. \u7b2c53\u56de\u65e5\u672c\u6ccc\u5c3f\u5668\u79d1\u5b66\u4f1a\u7fa4\u99ac\u5730\u65b9\u4f1a, 2009\u5e7411\u67087\u65e5, \u524d\u6a4b.<\/li>\n
  60. \u91ce\u6751\u660c\u53f2\u3001\u5c0f\u6c60\u79c0\u548c\u3001\u677e\u4e95\u3000\u535a\u3001\u67f4\u7530\u5eb7\u535a\u3001\u7fbd\u9ce5\u57fa\u660e\u3001\u4f0a\u85e4\u4e00\u4eba\u3001\u9234\u6728\u548c\u6d69\u3001\u5c0f\u6797\u5e79\u7537\uff1a\u8179\u8154\u93e1\u4e0b\u526f\u814e\u6458\u9664\u8853\u306e\u81e8\u5e8a\u7684\u691c\u8a0e. \u7b2c53\u56de\u65e5\u672c\u6ccc\u5c3f\u5668\u79d1\u5b66\u4f1a\u7fa4\u99ac\u5730\u65b9\u4f1a, 2009\u5e7411\u67087\u65e5, \u524d\u6a4b.<\/li>\n
  61. \u53e4\u8c37\u6d0b\u4ecb\u3001\u9ed2\u5ddd\u516c\u5e73\u3001\u6e05\u6c34\u96c4\u81f3\uff1a\u30a6\u30d6\u30ec\u30c1\u30c9\u306b\u3088\u308b\u30b3\u30ea\u30f3\u4f5c\u52d5\u6027\u30af\u30ea\u30fc\u30bc\u306e\u4e00\u4f8b. \u7b2c53\u56de\u65e5\u672c\u6ccc\u5c3f\u5668\u79d1\u5b66\u4f1a\u7fa4\u99ac\u5730\u65b9\u4f1a, 2009\u5e7411\u67087\u65e5, \u524d\u6a4b.<\/li>\n
  62. \u5bae\u6fa4\u6176\u884c\u3001\u4f50\u3005\u6728\u9756\u3001\u4e2d\u91ce\u52dd\u4e5f\u3001\u4e2d\u7530\u8aa0\u53f8\u3001\u9ad8\u6a4b\u6ea5\u670b\u3001\u6e05\u6c34\u548c\u5f66\uff1a\u30e0\u30c1\u30f3\u7523\u751f\u6027\u4f4e\u5206\u5316\u817a\u764c\u306e\u4e00\u4f8b. \u7b2c53\u56de\u65e5\u672c\u6ccc\u5c3f\u5668\u79d1\u5b66\u4f1a\u7fa4\u99ac\u5730\u65b9\u4f1a, 2009\u5e7411\u67087\u65e5, \u524d\u6a4b.<\/li>\n
  63. \u4f0a\u85e4\u4e00\u4eba\uff1a\u524d\u7acb\u817a\u304c\u3093\u691c\u8a3a\uff5e\u73fe\u72b6\u3068\u4eca\u5f8c\u306e\u8ab2\u984c\uff5e. \u65e5\u672c\u81e8\u5e8a\u691c\u67fb\u81ea\u52d5\u5316\u5b66\u4f1a\u7b2c41\u56de\u5927\u4f1a \u30e9\u30f3\u30c1\u30e7\u30f3\u30bb\u30df\u30ca\u30fc\uff13, 2009\u5e7410\u67089\u65e5, \u6a2a\u6d5c.<\/li>\n
  64. \u4f0a\u85e4\u4e00\u4eba\uff1aPSA\u691c\u8a3a\uff1a\u63fa\u308b\u304e\u306a\u3044\u771f\u5b9f\u3068\u63fa\u308c\u308b\u5831\u9053. \u7b2c31\u56de\u6771\u4e09\u6cb3\u6ccc\u5c3f\u5668\u79d1\u533b\u4f1a\u7814\u4fee\u4f1a\u3000\u7279\u5225\u8b1b\u6f14, 2009\u5e749\u670819\u65e5, \u8c4a\u6a4b.<\/li>\n
  65. \u4f0a\u85e4\u4e00\u4eba\uff1aPSA\u691c\u8a3a\uff1a\u63fa\u308b\u304e\u306a\u3044\u4e8b\u5b9f\u3068\u63fa\u308c\u308b\u5831\u9053. \u7b2c13\u56de\u6ccc\u5c3f\u5668\u79d1\u61c7\u8a71\u4f1a\u3000\u7279\u5225\u8b1b\u6f14, 2009\u5e745\u670815\u65e5, \u5927\u962a.<\/li>\n
  66. \u4f0a\u85e4\u4e00\u4eba\uff1a\u4e2d\uff0f\u9ad8\u30ea\u30b9\u30af\u524d\u7acb\u817a\u764c\u306e\u653e\u5c04\u7dda\u6cbb\u7642. \u7b2c\uff15\u56deGUTR\u7814\u7a76\u4f1a \u7279\u5225\u8b1b\u6f14(\u30a4\u30d6\u30cb\u30f3\u30b0\u30bb\u30df\u30ca\u30fc), 2009\u5e7410\u670824\u65e5, \u6a2a\u6d5c.<\/li>\n
  67. \u4f0a\u85e4\u4e00\u4eba\uff1aPSA\u691c\u8a3a\u306e\u8a55\u4fa1\u306f\u6fc0\u5909\uff1a\u591a\u3044\u30e1\u30ea\u30c3\u30c8\u3068\u5c11\u306a\u3044\u30c7\u30e1\u30ea\u30c3\u30c8. \u7b2c\uff15\u56de\u798f\u5ca1\u524d\u7acb\u817a\u304c\u3093\u691c\u8a3a\u30bb\u30df\u30ca\u30fc \u7279\u5225\u8b1b\u6f14, 2009\u5e749\u670815\u65e5, \u798f\u5ca1.<\/li>\n
  68. \u4f0a\u85e4\u4e00\u4eba\uff1aPSA\u30b9\u30af\u30ea\u30fc\u30cb\u30f3\u30b0\uff1a\u63fa\u308b\u304e\u306a\u3044\u4e8b\u5b9f\u3068\u63fa\u308c\u308b\u5831\u9053. \u7b2c92\u56de\u5c71\u5f62\u6ccc\u5c3f\u5668\u79d1\u7814\u7a76\u4f1a\uff1a\u540c\u9580\u4f1a\u7279\u5225\u30ec\u30af\u30c1\u30e3\u30fc , 2009\u5e746\u670813\u65e5, \u5c71\u5f62.<\/li>\n
  69. \u4f0a\u85e4\u4e00\u4eba\uff1aPSA\u691c\u8a3a\u306e\u771f\u5b9f\uff1a\u306a\u305c\u591a\u304f\u306e\u75ab\u5b66\u8005\u306f\u53cd\u5bfe\u3059\u308b\u306e\u304b . \u5c71\u53e3\u770c\u6771\u90e8\u6ccc\u5c3f\u5668\u79d1\u7814\u7a76\u4f1a \u7279\u5225\u8b1b\u6f14, 2009\u5e7412\u67083\u65e5, \u5fb3\u5c71.<\/li>\n
  70. \u4f0a\u85e4\u4e00\u4eba\uff1a\u524d\u7acb\u817a\u764c\u691c\u8a3a\u306e\u73fe\u72b6\u3068\u8a55\u4fa1\uff1a\u5c71\u4e2d\u82f1\u58fd\u540d\u8a89\u6559\u6388\u3000\u524d\u7acb\u817a\u7814\u7a76\u8ca1\u56e3\u7406\u4e8b\u9577\u5c31\u4efb\/\u7fa4\u99ac\u5927\u5b66\u533b\u5b66\u90e8\u6ccc\u5c3f\u5668\u79d1\u6559\u5ba4\u958b\u8a2d\u8a18\u5ff5\u30d1\u30fc\u30c6\u30a3\u30fc\uff1a\u7b2c\uff11\u90e8\u3000\u524d\u7acb\u817a\u764c\u691c\u8a3a\u5b66\u8853\u8b1b\u6f14\u4f1a\uff1a\u57fa\u8abf\u8b1b\u6f14. 2009\u5e7410\u67083\u65e5, \u524d\u6a4b.<\/li>\n
  71. \u4f0a\u85e4\u4e00\u4eba\uff1aPSA\u30b9\u30af\u30ea\u30fc\u30cb\u30f3\u30b0\uff1a\u63fa\u308b\u304e\u306a\u3044\u771f\u5b9f\u3068\u63fa\u308c\u308b\u5831\u9053. \u7b2c152\u56de\u5bae\u5d0e\u770c\u6ccc\u5c3f\u5668\u79d1\u533b\u4f1a\u3000\u7279\u5225\u8b1b\u6f14, 2009\u5e749\u670824\u65e5, \u5bae\u5d0e.<\/li>\n
  72. \u4f0a\u85e4\u4e00\u4eba\uff1a\u524d\u7acb\u817a\u304c\u3093\u691c\u8a3a\u306b\u95a2\u3059\u308b\u6700\u65b0\u306e\u7814\u7a76\u6210\u679c\u3068\u4eca\u5f8c\u306e\u5c55\u671b. \u7b2c\uff19\u56deXPC\u30d5\u30a9\u30fc\u30e9\u30e0 \u7279\u5225\u8b1b\u6f14, 2009\u5e741\u670824\u65e5, \u65b0\u5c45\u6d5c\u3001\u611b\u5a9b.<\/li>\n","protected":false},"excerpt":{"rendered":"

    Ito K, Miyamoto S, Yamamoto T, Suzuki K and Yamanaka H\uff1aImpact of pretreatment factors, biopsy Gleason grade vo […]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[6],"tags":[],"class_list":["post-31","post","type-post","status-publish","format-standard","hentry","category-society"],"_links":{"self":[{"href":"https:\/\/urology.dept.med.gunma-u.ac.jp\/index.php?rest_route=\/wp\/v2\/posts\/31","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/urology.dept.med.gunma-u.ac.jp\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/urology.dept.med.gunma-u.ac.jp\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/urology.dept.med.gunma-u.ac.jp\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/urology.dept.med.gunma-u.ac.jp\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=31"}],"version-history":[{"count":0,"href":"https:\/\/urology.dept.med.gunma-u.ac.jp\/index.php?rest_route=\/wp\/v2\/posts\/31\/revisions"}],"wp:attachment":[{"href":"https:\/\/urology.dept.med.gunma-u.ac.jp\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=31"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/urology.dept.med.gunma-u.ac.jp\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=31"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/urology.dept.med.gunma-u.ac.jp\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=31"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}